Key facts
- Tage Honore has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $750,556.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Tage Honore
- Location
- Washington, DC
- Summary
- The estimated net worth of Tage Honore is at least $750,556 dollars as of 24 Feb 2026. Tage Honore is the Director of Vanda Pharmaceuticals Inc. and owns shares of Vanda Pharmaceuticals Inc. (VNDA) stock worth about $750.6K.
- Signature
- /s/ Tage Honore
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Tage Honore and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: Vanda Pharmaceuticals Inc. ($750,556).
- Past-year value change for that position: -$240,900.
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Tage Honore
VNDA
Forms 3/4/5
Vanda Pharmaceuticals Inc.
- Relationship
- Director
- Holdings value
- $750,556
- Past year net change
- -$240,900
- Change %
- -24%
- Report period
- 23 Feb 2026
Insider Transactions Reported by Tage Honore:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.